November 21, 2016 - By Darrin Black · 0 Comments
Quotient Ltd (NASDAQ:QTNT) institutional sentiment increased to 2.43 in Q2 2016. Its up 1.32, from 1.11 in 2016Q1. The ratio has increased, as 10 active investment managers opened new or increased holdings, while 9 cut down and sold their holdings in Quotient Ltd. The active investment managers in our partner’s database now possess: 12.07 million shares, down from 12.08 million shares in 2016Q1. Also, the number of active investment managers holding Quotient Ltd in their top 10 holdings was flat from 1 to 1 for the same number . Sold All: 3 Reduced: 6 Increased: 7 New Position: 3.
Quotient Limited is a diagnostics company. The company has a market cap of $150.72 million. The Firm focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It currently has negative earnings. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.
The stock decreased 2.00% or $0.1 on November 18, hitting $4.9. Quotient Ltd (NASDAQ:QTNT) has declined 53.02% since April 19, 2016 and is downtrending. It has underperformed by 56.88% the S&P500.
According to Zacks Investment Research, “Quotient Limited is a commercial-stage transfusion diagnostics company. It is focused on supplying blood-grouping consumables and developing MosaiQ, a fully automated platform for use in donor centers and patient-testing sites. Quotient Limited is headquartered in Edinburgh, Scotland and Newton, Pennsylvania.”
Sio Capital Management Llc holds 9.24% of its portfolio in Quotient Ltd for 2.33 million shares. Cormorant Asset Management Llc owns 1.54 million shares or 1.69% of their US portfolio. Moreover, Visium Asset Management Lp has 1.29% invested in the company for 2.37 million shares. The New York-based Perceptive Advisors Llc has invested 1.21% in the stock. Birchview Capital Lp, a Vermont-based fund reported 58,200 shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 5 insider purchases, and 3 insider sales for $3.09 million net activity.
Ratings analysis reveals 100% of Quotient’s analysts are positive. Out of 2 Wall Street analysts rating Quotient, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $18 while the high is $30. The stock’s average target of $24.67 is 403.47% above today’s ($4.9) share price. QTNT was included in 3 notes of analysts from August 11, 2015. Jefferies initiated Quotient Ltd (NASDAQ:QTNT) rating on Tuesday, August 11. Jefferies has “Buy” rating and $30 price target. Zacks upgraded it to “Hold” rating and $18 target price in Friday, August 14 report. The company was maintained on Wednesday, November 4 by UBS.
More important recent Quotient Ltd (NASDAQ:QTNT) news were published by: Quotes.Wsj.com which released: “Quotient Ltd. QTNT (US: Nasdaq)” on April 12, 2014, also Seekingalpha.com published article titled: “Quotient Ltd.: Little Known Company With Near-Term Disruptive Technology”, Streetinsider.com published: “Form 8-K Quotient Ltd For: Oct 28” on October 31, 2016. More interesting news about Quotient Ltd (NASDAQ:QTNT) was released by: Zacks.com and their article: “Should You Get Rid of Quotient Limited (QTNT) Now?” with publication date: June 23, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Darrin Black